Prior to final Food and Drug Administration approval in August, UH, MetroHealth and the Cleveland Clinic gained access to the ...

Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially dose-limiting adverse effect of platinum-based chemotherapies that features pain and sensory deficits in the periphery.

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages Northwestern University economist ...

One of the most effective and widely used chemotherapy drugs in the world is also one of the most feared for a side effect ...

Preclinical findings suggest that psilocybin may protect sensory nerves from chemotherapy toxicity, but clinical trials are ...

The application is supported by the phase 3 SAFFRON trial, in which savolitinib plus osimertinib improved progression-free ...

Reeve opens up about a deeply personal health battle he’s been facing for months and shares why he chose to make his journey ...

Hemangiosarcoma is one of the most feared diagnoses in veterinary medicine. This aggressive cancer of blood vessel cells, ...

The same drugs powerful enough to kill cancer cells can also damage healthy tissue. UC Irvine researchers are trying to ...

Leukemia is a cancer of the blood-forming tissues, including the bone marrow, that leads to the uncontrolled production of abnormal blood cells. Different forms of the disease vary widely in how ...

Merck & Co., Inc. (NYSE:MRK) and Daiichi Sankyo announced on September 25 that they voluntarily withdrew the U.S. application ...

HUTCHMED said Tuesday that partner AstraZeneca (AZN) has submitted a New Drug Application to the US Food and Drug Administration for the lung-cancer fighting drugs Orpathys plus T ...